In Response to "Reexamining the molecular findings in specialized stromal tumors of the prostate"
Mod Pathol
.
2021 Nov;34(11):2082-2083.
doi: 10.1038/s41379-021-00916-5.
Epub 2021 Sep 8.
Authors
Andres M Acosta
1
,
Lynette M Sholl
2
3
,
Adrian Marino-Enriquez
2
3
,
Paola Dal Cin
2
3
4
,
Brendan C Dickson
5
,
Jennifer B Gordetsky
6
,
Michael R Pins
7
,
Jesse K McKenney
8
,
Christopher D Fletcher
2
Affiliations
1
Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
[email protected]
.
2
Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
3
Center for Advanced Molecular Diagnostics, Brigham and Women's, Boston, MA, USA.
4
Cytogenetics Laboratory, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
5
Department of Pathology, Mount Sinai Hospital and University of Toronto, Toronto, ON, Canada.
6
Department of Pathology and Microbiology, Vanderbilt University, Nashville, TN, USA.
7
Department of Pathology, Advocate Lutheran General Hospital, Park Ridge, IL, USA.
8
Robert J. Tomsich Pathology & Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH, USA.
PMID:
34497361
DOI:
10.1038/s41379-021-00916-5
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Male
Prostate / pathology
Prostatic Hyperplasia* / pathology
Prostatic Neoplasms* / pathology